Chromedx Corp (MNLIF) 0.0980 $MNLIF ChroMedX Announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Chromedx Corp (MNLIF) 0.0980 $MNLIF

ChroMedX Announces Appointment of Ash Kaushal as President and CEO
ACCESSWIRE - Tue Jul 26, 5:20AM CDT
TORONTO, ONTARIO / ACCESSWIRE / July 26, 2016 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and Point-of-care Testing (POCT) technologies is pleased to announce the appointment of Ash Kaushal as the Company's new President and CEO, effective immediately.

ChroMedX Reports on HemoPalm Development
ACCESSWIRE - Fri Apr 29, 3:30PM CDT
TORONTO, ON / ACCESSWIRE / April 29, 2016 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and Point-of-care Testing technologies is pleased to report on the Company's HemoPalm development programme.

ChroMedX Corp. Engages Conductive Technologies Inc. for Biosensor Development Programme
ACCESSWIRE - Wed Apr 20, 3:30PM CDT
TORONTO, ON / ACCESSWIRE / April 20, 2016 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce the engagement of Conductive Technologies Inc. (CTI) of York, Pennsylvania to assist with biosensor development on the Company's HemoPalm technology.

ChroMedX Completes Proof-of-Concept CO-oximetry and Bilirubin Prototype Development
ACCESSWIRE - Fri Dec 11, 3:21PM CST
TORONTO, ON / ACCESSWIRE / December 11, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) devices is pleased to report the development of a proof-of-concept prototype of the Company's HemoPalm(TM) analyzer and associated cartridge for measuring CO-oximetry and bilirubin*.

ChroMedX Engages Hochuen International Corp. for Improved Prototype Cartridge Production
ACCESSWIRE - Tue Dec 08, 3:17PM CST
TORONTO, ON / ACCESSWIRE / December 8, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to report that it has engaged Hochuen International Corp. to produce an enhanced version of its prototype HemoPalm cartridges.

ChroMedX Awarded a United States Patent on its Ultra Filtration Technology - Video News Alert on InvestmentPitch.com
Newsfile Corp - Tue Oct 20, 12:00PM CDT
full story)

ChroMedX Corp. Announces Closing of First Tranche of Private Placement
ACCESSWIRE - Fri Oct 16, 5:48PM CDT
TORONTO, ON / ACCESSWIRE / October 16, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that it has completed the first tranche of its previously announced non-brokered private placement (the "Offering", pursuant to which the Company issued and sold an aggregate of 1,750,000 units (each, a "Unit" of the Company at a price of CDN$0.20 per Unit for aggregate gross proceeds of CDN$350,000. Each Unit is comprised of one common share of the Company (a "Common Share" and one Common Share purchase warrant (a "Warrant", each Warrant entitling the holder thereof to acquire one Common Share at a price of $0.30 for a period of twenty-four (24) months from the closing date.

ChroMedX Corp. Awarded New United States Patent on Ultra Filtration Technology
ACCESSWIRE - Wed Oct 14, 3:15PM CDT
TORONTO, ON / ACCESSWIRE / October 14, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that the Company has been awarded a United States patent on its Ultra Filtration technology.

ChroMedX Corp. Announces Private Placement of Units
ACCESSWIRE - Fri Oct 09, 7:21PM CDT
TORONTO, ON / ACCESSWIRE / October 9, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that it intends to complete a non-brokered private placement (the "Offering" for gross proceeds of up to CDN$800,000 through the issuance of up to 4,000,000 units (each a "Unit" at a price of CDN$0.20 per Unit. Each Unit will be comprised of one common share of the Company (a "Common Share" and one Common Share purchase warrant (a "Warrant", each Warrant entitling the holder thereof to acquire one Common Share at a price of $0.30 for a period of twenty-four (24) months from the closing date.

ChroMedX Corp. Awarded Two New Patents on Ultra-Filtration Technology
ACCESSWIRE - Wed Sep 30, 3:12PM CDT
TORONTO, ON / ACCESSWIRE / September 30, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that the Company has been awarded two additional Canadian patents on its Automated Ultra Filtration (AUF) technology.

ChroMedX Callaborates with Biointerfaces Institute and Receives Grant
Newsfile Corp - Wed Sep 16, 3:08PM CDT
full story)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 83

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading
PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 38

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
IP Lawyer Chris Henry Returns to Latham: A Game Changer

Updated Category News Views 106

Welcome Home, Chris Henry! Folks, here's a headline that's making waves in the IP litigation water: Chris Henry has returned to Latham & Watkins, taking his place as a heavyweight partner in their Boston office. Now, if you're not deeply entangled in the world of high-stakes intellectual property (IP) disputes, you might shrug. But for tech companies embroiled in patent...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 78

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
Keiki Smiles Boosts Pediatric Dental Care in Waipahu

Updated Category News Views 122

A Neighborhood Dentists' Big Move: Keiki Smiles Expands in Waipahu Well, if there's one thing the dentists of Waipahu know how to do, it's adapt and grow. Keiki Smiles of Leeward, a trusted name in pediatric dentistry, just set up shop at a fresh location. The move marks a new chapter for this community staple, and honestly, it's miles more than just a longer lease and a...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 101

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
New York Reclaims Bagel Crown at 2026 BagelFest

Updated Category News Views 161

A Bagel Victory at Citi Field Holy schmear! New Yorker's are grinning wide like a bagel with a double helping of cream cheese—Ess-a-Bagel from Manhattan snagged the top honors at the heavily contested 2026 New York BagelFest. Back in its rightful hands, the Bagel Crown stays in the Empire State, and it's a victory for tradition and taste. Celebrating 50 years in the...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 142

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
Pinot's Palette Expands with New La Quinta Studio

Updated Category News Views 79

Canvas and Cabernet in Coachella Valley Grab your brushes and wine glasses; Pinot's Palette is branching out to La Quinta. As of November 27, locals and visitors alike can find their artistic flair at 47120 Dune Palms Road. This move isn’t just another business expansion—it's about blending community spirit with creativity, backed by the experienced entrepreneurs...

Continue Reading
Mars Moves on Cash Tender Offers for Seniors' Notes

Updated Category News Views 104

A Strategic Financial Maneuver or a Casual Gambit? Okay, what’s Mars up to now, you ask? Here we go with this. The behemoth behind some of your favorite snacks and pet indulgences is making waves—not with candy, but with cash. Mars, Incorporated is rolling out tender offers to buy back a substantial chunk of its Senior Notes for $2 billion in cold, hard cash. When a...

Continue Reading

Top 5 Most Recently Viewed Articles

Highlights and Expectations for AAR's Upcoming Earnings Call

Updated Category News Views 102

AAR's Upcoming Earnings Release AAR (NYSE:AIR) is set to unveil its quarterly earnings report soon. Investors keenly await this announcement, hoping for positive surprises both in earnings and guidance for the future. Analysts’ Earnings Expectations Analysts predict that AAR will post an earnings per share (EPS) of $1.03. This figure reflects the optimism surrounding...

Continue Reading
Tradeweb Markets Reports Significant Trading Volume Growth

Updated Category News Views 218

Tradeweb Markets Sees Record Trading Volume in January Tradeweb Markets Inc. (NASDAQ: TW), a premier global provider of electronic marketplaces for trading various financial instruments, reported a phenomenal total trading volume of $54.6 trillion for January 2025. This figure represents an average daily volume (ADV) of approximately $2.44 trillion, showcasing a robust...

Continue Reading
Cal Water Celebrates EPA Recognition for Water Efficiency Efforts

Updated Category News Views 73

California Water Service, trading under NYSE: CWT, scored a big win back in 2024 when it snagged the U. S. Environmental Protection Agency’s (EPA) WaterSense Excellence in Promoting WaterSense Labeled Products Award for the second consecutive year. This ain't just fluff; it reflects a serious commitment to pushing water-efficient solutions that resonate with their...

Continue Reading
Navigating Market Trends: Key Earnings Week Insights

Updated Category News Views 125

Market Trends Before Earnings As we enter a pivotal earnings week, investors are feeling the pressure as tech stocks have led the way downwards. This anticipated decline comes as many anticipate significant corporate earnings that could either uplift or hamper the current record-setting rally in the markets. Stock Performance and Investor Sentiment On this busy Monday...

Continue Reading
Revolutionizing Insurance Research: The Game-Changer ZORRO Discover

Updated Category News Views 145

Introduction to ZORRO Discover ZestyAI has unveiled a groundbreaking tool aimed at transforming the insurance industry: ZORRO Discover. This innovative generative AI agent is set to revolutionize the way insurers handle regulatory filings and competitive market analysis, potentially reshaping operational strategies across the board. Significance of ZORRO Discover...

Continue Reading